Antineoplastics

Diabetes mellitus, adrenal insufficiency and lack of efficacy: case report

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Nakamura T, et al. End-of-life impact of concurrent diabetes mellitus and adrenal insufficiency as immune-related adverse events in an advanced non-small cell lung cancer patient. Thoracic Cancer 13: 3073-3075, No. 21, Nov 2022. Available from: URL: http://doi.org/10.1111/1759-7714.14660

Antineoplastics. Reactions Weekly 1961, 46 (2023). https://doi.org/10.1007/s40278-023-41303-0

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.